Volcik, Kelly A <br/><br/>
Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects.  [electronic resource] 

 -  Birth defects research. Part A, Clinical and molecular teratology  Mar 2003 
 - 154-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1542-0752 
<br/><br/><label>Standard No.: </label>10.1002/bdra.10008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>California--epidemiology<br/>Case-Control Studies<br/>DNA--analysis<br/>Dietary Supplements<br/>Female<br/>Folic Acid--administration & dosage<br/>Genetic Predisposition to Disease<br/>Genome, Human<br/>Genotype<br/>Humans<br/>Infant, Newborn<br/>Methylenetetrahydrofolate Reductase (NADPH2)<br/>Odds Ratio<br/>Oxidoreductases Acting on CH-NH Group Donors--classification<br/>Polymerase Chain Reaction<br/>Pregnancy<br/>Risk<br/>Spinal Dysraphism--blood